Methods, devices and formulations for targeted endobronchial therapy

Patent Citations (18)

Non-Patent Literature (19)

• Combes A. et al., “Incidence and outcome of polymicrobial ventilator-associated pneumonia” Chest 121-1618 (2002).Applicant
• Consensus Conference Participants “Consensus Statement: Aerosols and Delivery Devices” Respiratory Care 45:589-596 (2000).Applicant
• Corley D.E. et al., “Reproducibility of the Histologic Diagnosis of Pneumonia Among a Panel of Four Pathologists” Chest 112:458 (1997).Applicant
• Eisenberg, J., et al., “A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized tobramycin study group,” Chest 111(4):955-962 (1997).Applicant
• Fink et al., “Aerosol Therapy in Mechanically Ventilated Patients: Recent Advances and New Techniques,” Seminars in Respir. Cril. Care Med. 21:184-201 (2000).Applicant
• Fuller, H.D., et al., Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Am. Rev. Respir Dis., 141:440-444 (1990).Applicant
• Girard et al., “Comparison of plasma concentrations of aerosolized pentamidine in nonventilated and ventilated patients with pneumocystosis,” Amer. Rev. Respir. Dis., 140:1607-1610 (1989).Applicant
• Hoffken G. and Niederman M.S., “Nosocomial Pneumonia: The Importance of De-escalating Strategy for Antibiotic Treatment of Pneumonia in the ICU” Chest 122:2183 (2002).Applicant
• Labiris, et al., “Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis,” Am J Respir Crit Care Med 160:1711-1716 (1999).Applicant
• Levy, J., et al., “Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum,” J Infect Dis 148(6):1069-76 (1983).Applicant
• MacIntyre, N., et al., Aerosol delivery to intubated, mechanically ventilated patients. Crit. Care Med, 13:81-84 (1985).Applicant
• O'Riordan et al., “Nebulizer Function During Mechanical Ventilation,” Am. Rev. Respir. Dis. 148:1117-1122 (1992).Applicant
• Palmer LB, et al., “Tracheal aspirates in chronically mechanically ventilated patients: a human model of gram-negative infection and airway inflammation,” Chest 108:1326-1332 (1995).Applicant
• Palmer, et al., Aerosolized antibiotics in mechanically ventilated patients: Delivery and Response. Crit. Care Med, 26:31-39 (1998).Applicant
• Pennington, J.E., “Penetration of antibiotics into respiratory secretions,” Rev Infect Dis 3(1):67-73 (1981).Applicant
• Ramsey, B.W., et al., “Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group,” N Engl J Med 340(1):23-30 (1999).Applicant
• Rello J. et al., “Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database” Chest 122:2115 (2002).Applicant
• Wood et al., “Aerosolized Antimicrobial Therapy in Acutely Ill Patients,” Pharmacotherapy 20(2):166-181 (2000).Applicant
• Wood et al., “Aerosolized Ceftazidime for Prevention of Ventilator-associated Pneumonia and Drug Effects on the Proinflammatory Response in Critically Ill Trauma Patients,” Pharmacotherapy 22(8):972-982 (2002).Applicant